MAXIMUS, Inc. (NYSE:MMS) was downgraded by investment analysts at Jefferies Group LLC from a “buy” rating to a “hold” rating in a research note issued to investors on Friday, May 5th. They presently have a $64.00 price objective on the health services provider’s stock, up from their previous price objective of $63.00. Jefferies Group LLC’s price objective would suggest a potential upside of 2.14% from the stock’s current price.
A number of other analysts have also weighed in on the stock. Zacks Investment Research upgraded shares of MAXIMUS from a “sell” rating to a “hold” rating in a research note on Thursday, January 12th. Canaccord Genuity restated a “buy” rating and set a $62.00 price objective on shares of MAXIMUS in a research note on Friday, April 7th. Avondale Partners reaffirmed a “market perform” rating and set a $58.00 price target on shares of MAXIMUS in a report on Tuesday, January 17th. Finally, Maxim Group downgraded shares of MAXIMUS from a “buy” rating to a “hold” rating and set a $66.00 price target on the stock. in a report on Thursday, May 4th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company. MAXIMUS has a consensus rating of “Hold” and an average target price of $61.33.
MAXIMUS (NYSE:MMS) traded up 0.26% during trading on Friday, hitting $62.66. 277,865 shares of the stock were exchanged. MAXIMUS has a 52 week low of $43.69 and a 52 week high of $64.25. The firm’s 50-day moving average is $61.11 and its 200 day moving average is $57.99. The firm has a market cap of $4.06 billion, a PE ratio of 20.54 and a beta of 1.13.
MAXIMUS (NYSE:MMS) last released its quarterly earnings data on Thursday, May 4th. The health services provider reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.02. The business had revenue of $622 million during the quarter, compared to analyst estimates of $620.24 million. MAXIMUS had a net margin of 8.08% and a return on equity of 26.42%. MAXIMUS’s revenue was up 2.6% compared to the same quarter last year. During the same period last year, the business earned $0.74 EPS. Analysts expect that MAXIMUS will post $3.05 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 31st. Investors of record on Monday, May 15th will be issued a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date of this dividend is Thursday, May 11th. MAXIMUS’s payout ratio is 5.98%.
In other MAXIMUS news, President Bruce Caswell sold 17,197 shares of MAXIMUS stock in a transaction that occurred on Thursday, May 11th. The shares were sold at an average price of $62.47, for a total transaction of $1,074,296.59. Following the transaction, the president now owns 27,904 shares of the company’s stock, valued at $1,743,162.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Russell A. Beliveau sold 1,500 shares of MAXIMUS stock in a transaction that occurred on Tuesday, May 16th. The shares were sold at an average price of $63.82, for a total transaction of $95,730.00. Following the transaction, the director now directly owns 41,829 shares in the company, valued at approximately $2,669,526.78. The disclosure for this sale can be found here. In the last three months, insiders sold 86,027 shares of company stock worth $5,289,169. 3.10% of the stock is currently owned by insiders.
Several large investors have recently added to or reduced their stakes in the stock. Neuburgh Advisers LLC boosted its stake in MAXIMUS by 1.9% in the first quarter. Neuburgh Advisers LLC now owns 1,696 shares of the health services provider’s stock valued at $105,000 after buying an additional 32 shares during the last quarter. Acrospire Investment Management LLC boosted its stake in MAXIMUS by 183.3% in the first quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock valued at $106,000 after buying an additional 1,100 shares during the last quarter. First Bank & Trust bought a new stake in MAXIMUS during the fourth quarter valued at about $135,000. Glen Harbor Capital Management LLC boosted its stake in MAXIMUS by 1.9% in the first quarter. Glen Harbor Capital Management LLC now owns 2,332 shares of the health services provider’s stock valued at $145,000 after buying an additional 44 shares during the last quarter. Finally, Elkfork Partners LLC bought a new stake in MAXIMUS during the fourth quarter valued at about $162,000. Hedge funds and other institutional investors own 98.74% of the company’s stock.
MAXIMUS Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for MAXIMUS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS Inc. and related companies with MarketBeat.com's FREE daily email newsletter.